![Burning Questions in Inflammatory Bowel Disease: Learnings from Emerging Drug Options and Clinical Cases - European Medical Journal Burning Questions in Inflammatory Bowel Disease: Learnings from Emerging Drug Options and Clinical Cases - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2019/12/Gastro-8.1.jpg)
Burning Questions in Inflammatory Bowel Disease: Learnings from Emerging Drug Options and Clinical Cases - European Medical Journal
![PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/322890443_DOP028_Second_N-ECCO_Consensus_Statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5c7fc64592851c69505a7e20/largepreview.png)
PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
![Cancers | Free Full-Text | Altered Plasma, Urine, and Tissue Profiles of Sulfatides and Sphingomyelins in Patients with Renal Cell Carcinoma Cancers | Free Full-Text | Altered Plasma, Urine, and Tissue Profiles of Sulfatides and Sphingomyelins in Patients with Renal Cell Carcinoma](https://www.mdpi.com/cancers/cancers-14-04622/article_deploy/html/images/cancers-14-04622-g004.png)
Cancers | Free Full-Text | Altered Plasma, Urine, and Tissue Profiles of Sulfatides and Sphingomyelins in Patients with Renal Cell Carcinoma
![PDF) Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy PDF) Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy](https://i1.rgstatic.net/publication/334065147_Systemic_Molecular_Mediators_of_Inflammation_Differentiate_Between_Crohn's_Disease_and_Ulcerative_Colitis_Implicating_Threshold_Levels_of_IL-10_and_Relative_Ratios_of_Pro-inflammatory_Cytokines_in_The/links/5ef6476a92851c52d6febd47/largepreview.png)
PDF) Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy
![D-ECCO on Twitter: D-ECCO on Twitter:](https://pbs.twimg.com/media/D1JD6YkX0AEWCkX.jpg)
D-ECCO on Twitter: "Hugh thanks to all the speakers & delegates @D_ECCO_IBD workshop today. Highlighting the importance of MDT working & ongoing quality research to manage IBD #IBD #ECCO2019 #ECCO19 #DECCO @KGerasimidis @
![PDF) Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: Medical treatment PDF) Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: Medical treatment](https://i1.rgstatic.net/publication/352704305_Biologics_recommendations_in_the_ECCO_guidelines_on_therapeutics_in_Crohn's_disease_Medical_treatment/links/60d9c15392851ca9449080ce/largepreview.png)